KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Elanco Animal Health (ELAN) Short-Term Debt repayments (2021 - 2025)

Elanco Animal Health's Short-Term Debt repayments history spans 5 years, with the latest figure at $85.0 million for Q2 2025.

  • For Q2 2025, Short-Term Debt repayments changed N/A year-over-year to $85.0 million; the TTM value through Dec 2025 reached $125.0 million, down 50.0%, while the annual FY2025 figure was $125.0 million, 50.0% down from the prior year.
  • Short-Term Debt repayments for Q2 2025 was $85.0 million at Elanco Animal Health, up from $40.0 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $575.0 million in Q2 2022 and bottomed at -$250.0 million in Q4 2021.
  • The 5-year median for Short-Term Debt repayments is $85.0 million (2025), against an average of $106.5 million.
  • The largest YoY upside for Short-Term Debt repayments was 1050.0% in 2022 against a maximum downside of 25.0% in 2022.
  • A 5-year view of Short-Term Debt repayments shows it stood at -$250.0 million in 2021, then soared by 130.0% to $75.0 million in 2022, then decreased by 4.0% to $72.0 million in 2023, then soared by 177.78% to $200.0 million in 2024, then plummeted by 57.5% to $85.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Short-Term Debt repayments are $85.0 million (Q2 2025), $40.0 million (Q1 2025), and $200.0 million (Q3 2024).